“Engaged speakers and relevant topics puts this conference on my need to attend list each year!” – 2010 Attendee, Richard Morris, Controller and Chief Accounting Officer, ViroPharma Inc.

CBI’s annual Pharma/Biotech Accounting and Reporting Congress is the must-attend event for senior-level Finance, Accounting, Audit and Reporting professionals!  This meeting provides updates on changing regulations, technical accounting guidelines, auditing strategies and financial reporting best practices.  Most importantly, it is uniquely tailored for the specific challenges and requirements of pharmaceutical and biotech companies.

Hear Expert Insights on:

• SEC, FASB, IASB and PCAOB hot topics

• IFRS adoption

• Revenue recognition and collaboration accounting

• Financial disclosures

• Gross-to-net deductions and accruals

• Capitalizing and accounting for R&D expenses

• Valuation and impairment of intangible assets

• Impact of the credit crisis and cash flow forecasting

Other CBI Financial Series Events

Hear what some of our previous attendees had to say:

“Annual opportunity to get the collective wisdom of the regulators, auditors and best in class consultants.” – Ray Minogue, Director of SEC Reporting, Par Pharmaceuticals

“This conference lived up to its reputation.  Great speakers, great content on hot topics makes this one of the best conferences I have attended.” – Katie Kapadia, Vice President, Internal Audit, Elan Pharmaceuticals, Inc.

“Probably the best conference for Pharma/Biotech accounting professionals out there. Top notch presenters and comprehensive review of most current finance/accounting hot topics.” – Edward Stelmakh, Vice President Corporate Financial Planning and Analysis, Mylan

“I was surprised at the level of detail and the precision of content that the presenters gave.  I got a lot of information!” – Kimberlee Gonzaga, Chief Financial Officer, Juvaris Biotherapeutics Inc.

“I always get at least one key takeaway, which is worth significantly more than the cost to attend the conference!” – Dave Lowrance, CFO, Cumberland Pharmaceuticals

“This conference has developed into one of the most valuable conferences of the year for accounting and financial reporting professionals in our industry.  Highly recommended!” – Doug McCorkle, VP and Controller, Regeneron Pharmaceuticals

“Even for a private company, this conference is very insightful with many practical takeaways.” – Rob Burgess, CFO and VP of Administration, Merz Pharma 

“The Pharma/Biotech Accounting and Reporting Congress provides participants the opportunity to network with and learn from some of the top professionals in the industry.  It is a unique conference, geared towards preparers.” – Lewis Dulitz, Vice President, Accounting Policies and Research, Covidien

 “The conference is a great opportunity to network and stay current on relevant topics facing the industry.” – Mark Cupo, Senior Director of Accounting and Reporting, sanofi-aventis

“The conference provided an opportunity for companies to share best practices and ideas, what is of great value in the globalization of our business practices.” – Duane Doucette, Senior Manager, Amgen 

“Very relevant and current information for any accounting personnel working in the Pharma industry.” – Ira Duarte, Director of Accounting, Cornerstone Therapeutics

“The material was current and pertinent to major issues facing the industry.” – Michael Fipps, Chief Financial Officer, Osmotica Pharmaceutical Corp.

“Excellent topics and applicable focus.  Converging accounting and finance issues, with industry developments was excellent!” – Jim Mastakas. Controller, Sandoz

“Excellent relevant revenue recognition information for all biotech finance and accounting professionals.” – Deborah Schaub, Controller, Ceres

“An excellent mix of technical accounting issues facing large and small pharma companies, as well as economic and political issues impacting the industry.” – Bob Hauer, VP and Controller, Wyeth Pharmaceuticals

 “The seminar is a great review of hot issues the industry is facing.” – Chris Nicholas, Controller, Shire

“Engaged speakers and relevant topics puts this conference on my need to attend list each year!” – Richard Morris, Controller and Chief Accounting Officer, ViroPharma Inc.

“Speakers were very good and provided useful examples to help understanding.” – Christopher Giolli, AVP Finance and CFO, Wyeth

“Not only timely information and great networking each year, but after five years the conference is attracting very influential speakers.” – Debra Mohollen, Assistant Controller, Viro Pharma

“This conference continues to be particularly beneficial to financial reporting professionals in the pharma/biotech industry.  Highly recommended!” – Douglas McCorkle, Vice President and Controller, Regeneron Pharmaceuticals

“This conference is full of information that adds value to your career and your ability to add value to your company.” – Ray Minogue, Director of SEC Reporting, Par Pharmaceuticals

“One of the few conferences where you get real insight into the pharma industry and its stakeholders.”  – Brian Staalkjaer, Corporate Accounting Manager, Novo Nordisk

“A great opportunity to gain knowledge on issues being faced by the pharmaceutical industry today, as well as networking with the individuals who deal with them.” – Keith Ruck, Corporate Controller, Lannett

“The conference was an excellent vehicle for better understanding of accounting changes, the future of accounting changes and understanding where my peer group stands on similar issues.” – Nancy Stempin, Director of Finance, Novartis

“Great Content.  Great Speakers.  Relevant Industry Topics.” – Lauren Riker, Senior Director of Financial Reporting, Ikana

“Great exposure to issues in accounting.” – Tint Tint Yap, Director of Accounting, Bayer Healthcare

For more information or to register, please contact the Center for Business Intelligence toll free by phone at 1-800-817-8601 or via e-mail at cbireg@cbinet.com.